Presentaciones de la sesión
09:00
Clinical evaluation of dual-frequency (6.78 MHz and 2.0 MHz) monopolar radiofrequency treatment: monotherapy versus combination with HIFU, stratified
10:00
From inflammation to regeneration: microenvironment reprogramming using activated PRF
10:12
Repositioning non-ablative fractional lasers - molecular and histological insights reveal new therapeutic potential
10:24
How to utilize a needle-free jet injector effectively: from scar revision to global rejuvenation
10:36
Neurocutaneous determinants of treatment response following energy-based device procedures in skin of color
11:12
From filling to structural repositioning: a novel bio-mechanical strategy for sunken eyes via myo-restoration
11:24
Periocular rejuvenation through a multilevel structural approach in a previously treated patient with suboptimal outcomes: a case report
11:36
Tiered full-face rejuvenation in a filler-naive 65 year-old asian female: synergistic effects of MD codes and variable HA concentrations
12:00
Efficacy of non crosslinked high molecular weight hyaluronic acid for non-surgical face lift
12:12
Combined 755-nm picosecond laser and microneedling-assisted delivery of tranexamic acid, niacinamide, GABA, and exosomes for melasma in asian women
12:24
Anatomy-based facial contour filling in asians with minimally invasive injections
12:36
The italian method of natural skin regeneration advanced synergy of calcium hydroxyapatite, hyaluronic acid, and polynucleotides
14:00
Repetitive superficial scar filler technique: consistent long-term results at 13, 15, 18 and 24 months with live procedural demonstration
14:12
A correlation study between PASI and fasting blood glucose levels in psoriasis patients with diabetes
14:24
Management of papular reaction with tram-track scarring and post-inflammatory hyperpigmentation following micro needling radio frequency
14:36
EBD to nodules: trigger or treatment? A complication-aware algorithm for managing nodules after fillers and collagen stimulators
14:48
An open label one arm clinical trial to assess the efficacy of intralesional tranexamic acid in the treatment of melasma patients from eastern India
